HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Reaction

Magnesium Hydroxide → CID 64738

HRID 859095
Print

Reaction equation

HRID 859095 reaction equation
[OH-].[Mg+2:2].[OH-].[C:4]([O-:13])(=[O:12])[C:5]1[C:6](=[CH:8][CH:9]=[CH:10][CH:11]=1)[OH:7].[Na+]>O>[C:4]([O-:13])(=[O:12])[C:5]1[C:6](=[CH:8][CH:9]=[CH:10][CH:11]=1)[OH:7].[Mg+2:2].[C:4]([O-:13])(=[O:12])[C:5]1[C:6](=[CH:8][CH:9]=[CH:10][CH:11]=1)[OH:7]
ParticipantsProcedureSources & evidenceReaction notes

Participants

4

Reactant 2

HCID 73981Magnesium HydroxideHCID 16760658Sodium Salicylate

Product 1

HCID 64738CID 64738

Reagents, catalysts & solvents 1

HCID 962WaterSolvent

Procedure

Magnesium hydroxide (0.0116 g; 0.0002 mol) is dissolved in 100 ml of water by gradual stirring. 0.03 g (0.0002 mols) of sodium salicylate is added to the solution to yield a magnesium salicylate molar ratio of 1:1. The resulting solution added to a 300 ml solution containing 0.225 g of membrane translocating peptide. The resulting solution is stirred at 4° Celsius for 12 hours and lyophilized to a volume of 200 ml. The solution is left to precipitate an inventive complex. The complex is filtered, washed with ether and purified commensurate with pharmaceutical purity requirements.

Sources & evidence

ORD record
ord-b473986c9968452e9e24d2584d770049
Source dataset
uspto-grants-2006_12
DOI
10.6084/m9.figshare.5104873.v1
Patent number
US07151084B2

Reaction notes

On this pageParticipantsProcedureSources & evidenceReaction notes